ES2172681T3 - Piramidinas y triazinas sustituidas con amino. - Google Patents

Piramidinas y triazinas sustituidas con amino.

Info

Publication number
ES2172681T3
ES2172681T3 ES96934690T ES96934690T ES2172681T3 ES 2172681 T3 ES2172681 T3 ES 2172681T3 ES 96934690 T ES96934690 T ES 96934690T ES 96934690 T ES96934690 T ES 96934690T ES 2172681 T3 ES2172681 T3 ES 2172681T3
Authority
ES
Spain
Prior art keywords
rent
hydrogen
amino
replaced
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96934690T
Other languages
English (en)
Inventor
Thomas R Webb
Terence J Moran
James R Mccarthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Neurocrine Biosciences Inc
Original Assignee
Janssen Pharmaceutica NV
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV, Neurocrine Biosciences Inc filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2172681T3 publication Critical patent/ES2172681T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom

Abstract

PIRIMIDINAS Y TRIAZINAS DE FORMULA (I), DONDE R ES ALQUILO C 1-6 , AMINO, MONO- O DIALQUIL C 1-6 AMINO; R 1 ES HIDROGENO, ALQUILO C 1-6 , ALQUENILO C 3-6 , HIDROXIALQUILO C 1-6 O ALQUILOXI C 1-6 - ALQUILO C 16 ; R 2 ES ALQUILO C 1-6 , MONO- O DICICLOALQUIL C SU B,3-6 METILO, FENILMETILO, FENILMETILO SUSTITUIDO, ALQUILOXI C1-6 - ALQUILO C 1-6 , HIDROXIALQUILO C 1-6 , ALQ UIL C 1-6 OXICARBONILALQUILO C 1-6 , ALQUENILO C 3-6 ; O R 1 Y R 2 JUNTO CON EL NITROGENO AL QUE ESTAN UNIDOS PUEDEN FORMAR UN GRUPO PIRROLIDINILO, MORFOLINILO O PIPERIDINILO; X ES N O CR 3 ; R 3 ES HIDROGENO O ALQUILO C 1-6 ; R 4 ES FENILO O FENILO SUSTITUIDO; A ES - C(=O) -, (A), O - CR 7 R 8 - DONDE R 5 Y R 6 S ON CADA UNO INDEPENDIENTEMENTE HIDROGENO O ALQUILO C 1-4 ; R 7 ES HIDROGENO O OH; R 8 ES HIDROGENO O ALQUILO C SUB,1-6 ; QUE TIENEN PROPIEDADES ANTAGONISTICAS DE RECEPTORES CRF; COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS COMO PRINCIPIOS ACTIVOS; METODOS PARA TRATAR DESORDENES RELACIONADOS CON LA HIPERSECRECION DE CRF TALES COMO DEPRESION, ANSIEDAD Y ABUSO DE SUSTANCIAS, MEDIANTE ADMINISTRACION DE UNA CANTIDAD EFECTIVA DE UN COMPUESTO DE FORMULA (I).
ES96934690T 1995-10-17 1996-10-15 Piramidinas y triazinas sustituidas con amino. Expired - Lifetime ES2172681T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US568795P 1995-10-17 1995-10-17

Publications (1)

Publication Number Publication Date
ES2172681T3 true ES2172681T3 (es) 2002-10-01

Family

ID=21717189

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96934690T Expired - Lifetime ES2172681T3 (es) 1995-10-17 1996-10-15 Piramidinas y triazinas sustituidas con amino.

Country Status (18)

Country Link
US (1) US6288060B1 (es)
EP (1) EP0863882B1 (es)
JP (1) JPH11513678A (es)
KR (1) KR19990045744A (es)
AR (1) AR004221A1 (es)
AT (1) ATE212987T1 (es)
AU (1) AU703096B2 (es)
CA (1) CA2229710A1 (es)
DE (1) DE69619125T2 (es)
DK (1) DK0863882T3 (es)
ES (1) ES2172681T3 (es)
MY (1) MY113945A (es)
NO (1) NO310771B1 (es)
NZ (1) NZ320227A (es)
PT (1) PT863882E (es)
TW (1) TW378206B (es)
WO (1) WO1997014684A1 (es)
ZA (1) ZA968732B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
DE19837387A1 (de) * 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
AU3357700A (en) * 1999-02-16 2000-09-04 E.I. Du Pont De Nemours And Company Phenoxypyrimidine insecticides and acaricides
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
EA200200424A1 (ru) 1999-09-30 2002-12-26 Ньюроджен Корпорейшн Некоторые гетероциклы, замещенные алкилендиамином
US6525067B1 (en) * 1999-11-23 2003-02-25 Pfizer Inc Substituted heterocyclic derivatives
AU2001234180A1 (en) * 2000-02-25 2001-09-03 Japan Tobacco Inc. Benzamide derivative and use thereof
WO2002006242A2 (en) * 2000-07-18 2002-01-24 Neurogen Corporation 5-substituted 2-aryl-4-pyrimidinones
ATE283844T1 (de) 2000-09-19 2004-12-15 Sumitomo Chemical Co Pyrimidinverbindungen und deren verwendung als pestizide
AU9625501A (en) 2000-09-21 2002-04-02 Bristol Myers Squibb Co Substituted azole derivatives as inhibitors of corticotropin releasing factor
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
CA2527079A1 (en) * 2003-05-29 2005-01-06 Synta Pharmaceuticals, Corp. Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2595697B1 (fr) 1986-03-13 1988-07-08 Rousselot Cie Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
FR2692893B1 (fr) 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
RU2153494C2 (ru) 1993-10-12 2000-07-27 Дзе Дюпон Мерк Фармасьютикал Компани 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция
TW530047B (en) * 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists

Also Published As

Publication number Publication date
ATE212987T1 (de) 2002-02-15
JPH11513678A (ja) 1999-11-24
NZ320227A (en) 1998-11-25
CA2229710A1 (en) 1997-04-24
NO310771B1 (no) 2001-08-27
AU7292996A (en) 1997-05-07
PT863882E (pt) 2002-07-31
US6288060B1 (en) 2001-09-11
KR19990045744A (ko) 1999-06-25
NO981623L (no) 1998-06-09
NO981623D0 (no) 1998-04-08
EP0863882A1 (en) 1998-09-16
AR004221A1 (es) 1998-11-04
ZA968732B (en) 1998-04-16
DE69619125D1 (de) 2002-03-21
DE69619125T2 (de) 2002-09-26
MY113945A (en) 2005-12-14
DK0863882T3 (da) 2002-05-06
AU703096B2 (en) 1999-03-18
WO1997014684A1 (en) 1997-04-24
EP0863882B1 (en) 2002-02-06
TW378206B (en) 2000-01-01

Similar Documents

Publication Publication Date Title
ES2172681T3 (es) Piramidinas y triazinas sustituidas con amino.
ES2168237T1 (es) Pirazolopirimidinas que actuan como antagonistas del receptor del crf.
FR2714378B1 (fr) Dérivés de l'indol-2-one substitués en 3 par un groupe azoté, leur préparation, les compositions pharmaceutiques en contenant.
EA200200417A1 (ru) Фармацевтически активные производные сульфонамида
IL96486A0 (en) Tricyclic compounds,their preparation and pharmaceutical compositions containing them
NZ330118A (en) Thiophenopyrimidines, pharmaceutical compositions thereof and use in treating endocrine, psychiatric and neurologic conditions
FI934274A0 (fi) N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner
FI862210A (fi) Imidazoheterocykliska foereningar och foerfarande foer deras framstaellning.
PT1158973E (pt) Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos
ATE15749T1 (de) Synergistische konservierungszusammensetzungen, diese enthaltende produkte und verfahren zu ihren gebrauch.
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
DE60234092D1 (de) Agonisten und antagonisten von sphingosin-1-phosphatrezeptoren
CA2272291A1 (en) Crf antagonistic quino- and quinazolines
ES2194452T3 (es) Composiciones antitranspirantes que contienen 1,2-hexanodiol.
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
DE3485318D1 (de) Oxopyrimidin-derivate und sie enthaltende pharmazeutische zubereitungen.
IL136911A0 (en) Heterocyclic topoisomerase poisons
YU168690A (sh) Novi preparati za zaštitu bilja sa površinski aktivnim agensima
BR9913757A (pt) Composto, e, agentes controladores de praga
ATE142421T1 (de) Fungizide zusammensetzung
DE69226931D1 (de) Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten
ES2078651T3 (es) Compuesto de piridinsulfonamida sustituida o una sal del mismo, procedimiento para su preparacion y herbicida que lo contiene.
BR9916383A (pt) Mistura fungicida, e, método para controlar os fungos nocivos
KR910011131A (ko) 모르폴린 및 트리아졸 기재의 상승 효과를 갖는 살균제 조성물
KR970073589A (ko) 항백내장제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 863882

Country of ref document: ES